186 related articles for article (PubMed ID: 28002966)
1. Development of Small Molecules with a Noncanonical Binding Mode to HIV-1 Trans Activation Response (TAR) RNA.
Abulwerdi FA; Shortridge MD; Sztuba-Solinska J; Wilson R; Le Grice SF; Varani G; Schneekloth JS
J Med Chem; 2016 Dec; 59(24):11148-11160. PubMed ID: 28002966
[TBL] [Abstract][Full Text] [Related]
2. Identification of biologically active, HIV TAR RNA-binding small molecules using small molecule microarrays.
Sztuba-Solinska J; Shenoy SR; Gareiss P; Krumpe LR; Le Grice SF; O'Keefe BR; Schneekloth JS
J Am Chem Soc; 2014 Jun; 136(23):8402-10. PubMed ID: 24820959
[TBL] [Abstract][Full Text] [Related]
3. Understanding the characteristics of nonspecific binding of drug-like compounds to canonical stem-loop RNAs and their implications for functional cellular assays.
Kelly ML; Chu CC; Shi H; Ganser LR; Bogerd HP; Huynh K; Hou Y; Cullen BR; Al-Hashimi HM
RNA; 2021 Jan; 27(1):12-26. PubMed ID: 33028652
[TBL] [Abstract][Full Text] [Related]
4. Face-time with TAR: Portraits of an HIV-1 RNA with diverse modes of effector recognition relevant for drug discovery.
Chavali SS; Bonn-Breach R; Wedekind JE
J Biol Chem; 2019 Jun; 294(24):9326-9341. PubMed ID: 31080171
[TBL] [Abstract][Full Text] [Related]
5. Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA.
Mischiati C; Jeang KT; Feriotto G; Breda L; Borgatti M; Bianchi N; Gambari R
Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):209-17. PubMed ID: 11572598
[TBL] [Abstract][Full Text] [Related]
6. Multivalency in the recognition and antagonism of a HIV TAR RNA-TAT assembly using an aminoglycoside benzimidazole scaffold.
Kumar S; Ranjan N; Kellish P; Gong C; Watkins D; Arya DP
Org Biomol Chem; 2016 Feb; 14(6):2052-6. PubMed ID: 26765486
[TBL] [Abstract][Full Text] [Related]
7. Recognition of HIV TAR RNA by triazole linked neomycin dimers.
Kumar S; Arya DP
Bioorg Med Chem Lett; 2011 Aug; 21(16):4788-92. PubMed ID: 21757341
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif.
Kundu M; Ansari SA; Chepenik LG; Pomerantz RJ; Khalili K; Rappaport J; Amini S
J Hum Virol; 1999; 2(2):72-80. PubMed ID: 10225209
[TBL] [Abstract][Full Text] [Related]
9. A small-molecule probe induces a conformation in HIV TAR RNA capable of binding drug-like fragments.
Davidson A; Begley DW; Lau C; Varani G
J Mol Biol; 2011 Jul; 410(5):984-96. PubMed ID: 21763501
[TBL] [Abstract][Full Text] [Related]
10. Binding of neomycin to the TAR element of HIV-1 RNA induces dissociation of Tat protein by an allosteric mechanism.
Wang S; Huber PW; Cui M; Czarnik AW; Mei HY
Biochemistry; 1998 Apr; 37(16):5549-57. PubMed ID: 9548939
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin inhibits Tat-dependent transactivation of HIV type 1 LTR.
Jeyaseelan R; Kurabayashi M; Kedes L
AIDS Res Hum Retroviruses; 1996 May; 12(7):569-76. PubMed ID: 8743082
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules.
Mei HY; Cui M; Heldsinger A; Lemrow SM; Loo JA; Sannes-Lowery KA; Sharmeen L; Czarnik AW
Biochemistry; 1998 Oct; 37(40):14204-12. PubMed ID: 9760258
[TBL] [Abstract][Full Text] [Related]
13. Fragment based search for small molecule inhibitors of HIV-1 Tat-TAR.
Zeiger M; Stark S; Kalden E; Ackermann B; Ferner J; Scheffer U; Shoja-Bazargani F; Erdel V; Schwalbe H; Göbel MW
Bioorg Med Chem Lett; 2014 Dec; 24(24):5576-5580. PubMed ID: 25466178
[TBL] [Abstract][Full Text] [Related]
14. Attenuating HIV Tat/TAR-mediated protein expression by exploring the side chain length of positively charged residues.
Wu CH; Chen YP; Liu SL; Chien FC; Mou CY; Cheng RP
Org Biomol Chem; 2015 Dec; 13(45):11096-104. PubMed ID: 26399751
[TBL] [Abstract][Full Text] [Related]
15. Synthetic HIV-1 Tat can dissociate HeLa nuclear protein-TAR RNA complexes in vitro: a novel Tat-nuclear protein interaction.
Jeyapaul J; Seshamma T; Khan SA
Oncogene; 1991 Sep; 6(9):1507-13. PubMed ID: 1923518
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and bioactivities of TAR RNA targeting beta-carboline derivatives based on Tat-TAR interaction.
Yu X; Lin W; Pang R; Yang M
Eur J Med Chem; 2005 Sep; 40(9):831-9. PubMed ID: 15925430
[TBL] [Abstract][Full Text] [Related]
17. RNA as a target for drug design, the example of Tat-TAR interaction.
Froeyen M; Herdewijn P
Curr Top Med Chem; 2002 Oct; 2(10):1123-45. PubMed ID: 12173971
[TBL] [Abstract][Full Text] [Related]
18. Identification of thienopyridine carboxamides as selective binders of HIV-1 trans Activation Response (TAR) and Rev Response Element (RRE) RNAs.
Li XD; Liu L; Cheng L
Org Biomol Chem; 2018 Dec; 16(47):9191-9196. PubMed ID: 30465585
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning and characterization of a TAR-binding nuclear factor from T cells.
Reddy TR; Suhasini M; Rappaport J; Looney DJ; Kraus G; Wong-Staal F
AIDS Res Hum Retroviruses; 1995 Jun; 11(6):663-9. PubMed ID: 7576925
[TBL] [Abstract][Full Text] [Related]
20. The design, synthesis, and biological evaluation of novel substituted purines as HIV-1 Tat-TAR inhibitors.
Yuan D; He M; Pang R; Lin SS; Li Z; Yang M
Bioorg Med Chem; 2007 Jan; 15(1):265-72. PubMed ID: 17055732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
